Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus | Contract Pharma

What are you searching for?

Sign in
Breaking News

Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus

Investment enhances Almac’s NGS portfolio of DNA sequencing service offerings.

By: Anthony Vecchione

Almac Diagnostic Services, a member of the Almac Group, expanded its next generation sequencing (NGS) capabilities for biopharma partners with the purchase and installation of the first Illumina NovaSeq X Plus instrument in Ireland.

The investment enhances Almac’s NGS portfolio of DNA sequencing service offerings, including whole genome sequencing, whole exome sequencing, and a range of RNA sequencing service offerings for biomarker discovery projects.

The Illumina NovaSeq X Plus enables larger sample runs and greater read depth, including both short and long-read sequencing, and faster speeds. According to the company, it will increase throughput, variant detection quality and accuracy, and reduce turnaround time and cost per sample for client biomarker research projects.

Additionally, the NovaSeq X Plus has 90 percent less packaging weight and waste, new compact cartridges and packaging design, and more recyclable plastics.

Michael Sloan, global vice president of commercial operations, Almac Diagnostic Services said, “Almac is at the cutting edge of NGS diagnostics.  Investing in this new instrument further enhances our DNA and RNA panel offerings, opens the potential for further expansion of our NGS solutions for clients and significantly increases overall sequencing capacity, ensuring that Almac continues to play a leading role within precision medicine.”


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters